Old API Wind-down Ltd - Ordinary Shares ARLZQ

Woo!

[GoldenDilemma]

With Trump winning and IBB handling it well, does that mean Deerfield maybe stops shorting this stock? 

Who knows - if they did have a short bias here in previous months (as I outlined in previous posts), it could have been to hedge the potential risk of Democratic scrutiny on the pharma sector. It may have also been a hedge against the entire IBB seemingly "stressed" by what Bernie and Hillary were spewing. Doesn't give much room for something to move up with that much negative sentiment.

Because, aside from us not having Q4'16/Q1'17 financials for ARLZ - the company has never been in a better position so this depreciation has been quite ludicrous.

In any case, just based on TA, the day chart for ARLZ looks great! What is key is whether these moves across the pharmaceutical sector fades in the coming days, or the sentiment remains. 

Note: no confirmation on a Deefield short... but, do consider it ;)

[kuatolives]

I wonder if this is a return to the price increases of the last couple of years. I really feel sorry for Americans if/when Obamacare gets scrapped. I know of at least a few people who are literally being kept alive by Obamacare and they'll be dead as doornails once these bozo's repeal it. Feel bad for Obama too; his one and only accomplishment in office may get turfed. Anyway, we'll

[Bigboyone]

Canadians just dont understand how big this is being that OBAMACARE may be scrapped..With Socialized medicine, its a gift. We in The US (Working class) went from example my monthly premium from $200 a month to over $700 a month. In theory the working class was supposed to pay in, but a large % where not. The Free lunch people (LARGE % OBAMA CARE) think that the govmt pays for the Healthcare, it

[kuatolives]

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; min-height: 14.0px} Obamacare, if I understand it properly, is probably not ideal because it tries to weave non-payers into for-profits. It doesn’t surprise me to hear that premiums are going up, and I think Kevin O’Leary just made a comment about that today on BNN where

[Bigboyone]

Yes, I was using a multiple of 3x for Aralez - I believe the multiple of 3-5x revenue.. is where almost all "Specialty Pharma" are about now.. 2.8x  probably will be  bumped a bit higher during the TRUMP (hoping) administration.. Just US Sales @ 250 Mil would be @ $25-$40 a share. Toprol-XL sales alone ended 3 months  (Sept) where $13.6 Mil, Fresh sales force, New Line of

[kuatolives]

We'll start seeing some green now, I think, a bit earlier than the Q4 results. Hopefully sentiment in biotech has finally turned.